| Literature DB >> 26339600 |
Courtney E Cross1, Mai F Tolba2, Catherine M Rondelli1, Meixiang Xu1, Sherif Z Abdel-Rahman1.
Abstract
The relationship between oxidative stress and miRNA changes in placenta as a potential mechanism involved in preeclampsia (PE) is not fully elucidated. We investigated the impact of oxidative stress on miRNAs and mRNA expression profiles of genes associated with PE in villous 3A first trimester trophoblast cells exposed to H2O2 at 12 different concentrations (0-1 mM) for 0.5, 4, 24, and 48 h. Cytotoxicity, determined using the SRB assay, was used to calculate the IC50 of H2O2. RNA was extracted after 4 h exposure to H2O2 for miRNA and gene expression profiling. H2O2 exerted a concentration- and time-dependent cytotoxicity on 3A trophoblast cells. Short-term exposure of 3A cells to low concentration of H2O2 (5% of IC50) significantly altered miRNA profile as evidenced by significant changes in 195 out of 595 evaluable miRNAs. Tool for annotations of microRNAs (TAM) analysis indicated that these altered miRNAs fall into 43 clusters and 34 families, with 41 functions identified. Exposure to H2O2 altered mRNA expression of 22 out of 84 key genes involved in dysregulation of placental development. In conclusion, short-term exposure of villous first trimester trophoblasts to low concentrations of H2O2 significantly alters miRNA profile and expression of genes implicated in placental development.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26339600 PMCID: PMC4538339 DOI: 10.1155/2015/257090
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1IC50 calculation for H2O2 after 30 min, 4 h, 24 hr, or 48 hr in villous 3A trophoblasts: 3A cells were exposed to varying concentrations (0, 2, 3, 6, 10, 20, 30, 60, 100, 200, 300, and 1000 μM) of H2O2 and IC50 determined using the SRB assay. Data represent n = 3 for each time point and concentration. IC50 was calculated using SigmaPlot v12.3.
Figure 2Pie chart representation for miRNome array results after 4 h exposure to H2O2 in villous 3A trophoblasts.
Clusters and families of miRNAs significantly altered by H2O2 in villous 3A trophoblasts.
| Count | Percentb |
| |
|---|---|---|---|
| Clustera | |||
| hsa-let-7e cluster | 3 | 100 | 0.0418 |
| hsa-let-106b cluster | 3 | 100 | 0.0418 |
| hsa-let-23b cluster | 3 | 100 | 0.0418 |
| Familya | |||
| let-7 family | 9 | 100 | 6.40 |
| mir-15 family | 4 | 100 | 0.0144 |
| mir-17 family | 6 | 75 | 0.0237 |
| mir-181 family | 4 | 100 | 0.0144 |
| mir-29 family | 3 | 100 | 0.0418 |
| mir-329 family | 3 | 100 | 0.0418 |
| mir-368 family | 3 | 100 | 0.0418 |
| mir-99 family | 3 | 100 | 0.0418 |
aAnalysis of overexpressed miRNAs was performed by TAM (tool for annotations of miRNAs, version 2). Size of miRNA category was set as 1–100.
bPercent of miRNA changed between treated and controls cells within the cluster or family.
c P < 0.05 indicates a significant number of miRNAs altered within a cluster/family.
Functional pathways regulated by miRNAs altered by H2O2 in villous 3A trophoblasts.
| Functiona | Count | Percentb |
|
|---|---|---|---|
| Angiogenesis | 14 | 61 | 7.9 |
| Apoptosis | 22 | 56 | 3.10 |
| Bone regeneration | 17 | 61 | 3.41 |
| Cell cycle related | 29 | 50 | 7.50 |
| Cell proliferation | 16 | 62 | 3.76 |
| Epithelial-mesenchymal transition | 24 | 63 | 1.72 |
| Folliculogenesis | 7 | 100 | 5.67 |
| Granulopoiesis | 9 | 90 | 4.48 |
| Hormones regulation | 29 | 54 | 1.77 |
| Human embryonic stem cell (hESC) regulation | 36 | 51 | 1.80 |
| Immune response | 29 | 73 | 3.36 |
| Inflammation | 22 | 65 | 2.02 |
| Adipocyte differentiation | 16 | 64 | 2.08 |
| Anticell proliferation | 11 | 100 | 1.07 |
| Brain development | 12 | 63 | 9.45 |
| Cell death | 31 | 62 | 2.54 |
| Cell division | 11 | 73 | 2.29 |
| Cell fate determination | 12 | 55 | 0.0415 |
| Hematopoiesis | 18 | 62 | 1.77 |
| Lipid metabolism | 11 | 58 | 0.0304 |
| miRNA tumor suppressors | 24 | 65 | 9.08 |
| Onco-miRNAs | 19 | 61 | 1.61 |
aAnalysis of altered miRNAs was performed by TAM (tool for annotations of miRNAs, version 2). Size of miRNA category was set as 1–100.
bPercent of miRNA changed between treated and controls cells within a pathway/function.
c P < 0.05 indicates a significant number of miRNAs altered within a pathway/function.
Figure 3Heat map representation for the differential expression of genes associated with PE after 4 h exposure to H2O2 in villous 3A trophoblasts. Gene expression is represented in the heat map in the color scale of −3.073–3.073 in green-red color scheme (n = 2). Genes evaluated and their locations on the heat map are depicted in the associated table above the heat map.
mRNAs altered by at least twofold after 4 h H2O2 exposure in villous 3A trophoblasts.
| Gene symbol | Gene description | Fold changeb |
|---|---|---|
|
| Heparin-binding EGF-like growth factor | 5.7637 |
| ANGPT2 | Angiopoietin 2 | −2.4932 |
| CCL2 | Chemokine (C-C motif) ligand 2 | −2.3834 |
| CD40LG | CD40 ligand | −2.2084 |
| CP | Ceruloplasmin (ferroxidase) | −2.2705 |
| CRH | Corticotropin releasing hormone | −2.1038 |
| DCN | Decorin | −2.0042 |
| HP | Haptoglobin | −2.4083 |
| IGF1 | Insulin-like growth factor 1 (somatomedin C) | −2.5991 |
| IL18 | Interleukin 18 (interferon-gamma-inducing factor) | −2.6445 |
| IL1A | Interleukin 1, alpha | −2.0748 |
| IL6 | Interleukin 6 (interferon, beta 2) | −2.0181 |
| LEP | Leptin | −8.4152 |
| LPL | Lipoprotein lipase | −2.2238 |
| MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | −2.0748 |
| NDRG1 | N-myc downstream regulated 1 | −2.5901 |
| NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | −2.6721 |
| PAPPA2 | Pappalysin 2 | −2.3102 |
| QPCT | Glutaminyl-peptide cyclotransferase | −2.5368 |
| SERPINA3 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | −2.1705 |
| TAC1 | Tachykinin, precursor 1 | −2.5368 |
| TNF | Tumor necrosis factor | −5.1266 |
aUpregulated gene is in bold font.
bFold change in H2O2 treated cells compared to nontreated control.
Altered miRNAs with putative altered mRNAs targets after 4 h exposure to H2O2 in villous 3A trophoblasts.
| miRNA name | Number of genes targeted by this miRNA | Number of target sites identified in target genes | Range of strength scoresa | Target genes |
|---|---|---|---|---|
| hsa-miR-181a-5p | 3 | 3 | −0.4593 to −0.234 | DCN, IL1A, TNF |
| hsa-miR-181c-5p | 3 | 3 | −0.4573 to −0.219 | DCN, IL1A, TNF |
| hsa-miR-181b-5p | 3 | 3 | −0.4593 to −0.234 | DCN, IL1A, TNF |
| hsa-miR-181d-5p | 3 | 3 | −0.4573 to −0.234 | DCN, IL1A, TNF |
| hsa-miR-27b-3p | 3 | 3 | −0.203 to −0.0872 | IGF1, LEP, LPL |
| hsa-miR-29a-3p | 3 | 4 | −0.4102 to −0.094 | IGF1, LEP, LPL |
| hsa-miR-29c-3p | 3 | 4 | −0.4102 to −0.09 | IGF1, LEP, LPL |
| hsa-miR-875-3p | 3 | 4 | −0.504 to −0.2443 | CD40LG, NDRG1, TNF |
| hsa-miR-9-5p | 3 | 3 | −0.453 to −0.0467 | IGF1, LEP, NDRG1 |
| hsa-miR-454-3p | 2 | 3 | −0.3152 to −0.219 | IGF1, TNF |
| hsa-miR-543 | 2 | 2 | −0.39 to −0.259 | ANGPT2, IL1A |
| hsa-miR-30e-5p | 2 | 2 | −0.452 to −0.1342 | IGF1, IL1A |
| hsa-miR-30b-5p | 2 | 2 | −0.452 to −0.1236 | IGF1, IL1A |
| hsa-miR-30a-5p | 2 | 2 | −0.452 to −0.1342 | IGF1, IL1A |
| hsa-miR-30c-5p | 2 | 2 | −0.452 to −0.1236 | IGF1, IL1A |
| hsa-miR-30d-5p | 2 | 2 | −0.452 to −0.1342 | IGF1, IL1A |
| hsa-miR-424-5p | 1 | 1 | −0.0766 to −0.0766 | IGF1 |
| hsa-miR-152-3p | 1 | 1 | −0.3972 to −0.3972 | IGF1 |
| hsa-miR-148b-3p | 1 | 1 | −0.3972 to −0.3972 | IGF1 |
| hsa-miR-425-5p | 1 | 1 | −0.4961 to −0.4961 | IGF1 |
| hsa-miR-16-5p | 1 | 1 | −0.0977 to −0.0977 | IGF1 |
| hsa-miR-497-5p | 1 | 1 | −0.0766 to −0.0766 | IGF1 |
| hsa-miR-490-5p | 1 | 1 | −0.197 to −0.197 | NTRK2 |
| hsa-miR-193a-5p | 1 | 1 | −0.115 to −0.115 | NTRK2 |
| hsa-miR-151a-5p | 1 | 1 | −0.401 to −0.401 | NTRK2 |
| hsa-miR-330-3p | 1 | 2 | −0.05 to −0.01 | NTRK2 |
| hsa-miR-17-5p | 1 | 2 | −0.149 to −0.148 | NTRK2 |
| hsa-miR-1271-5p | 1 | 1 | −0.108 to −0.108 | NDRG1 |
| hsa-miR-20a-5p | 1 | 2 | −0.17 to −0.148 | NTRK2 |
| hsa-miR-154-5p | 1 | 1 | −0.263 to −0.263 | NTRK2 |
| hsa-miR-26b-5p | 1 | 1 | −0.1205 to −0.1205 | IGF1 |
| hsa-miR-766-3p | 1 | 1 | −0.161 to −0.161 | IGF1 |
| hsa-miR-190a-5p | 1 | 1 | −0.1862 to −0.1862 | IGF1 |
| hsa-miR-452-5p | 1 | 1 | −0.3111 to −0.3111 | IGF1 |
| hsa-miR-320a | 1 | 1 | −0.1466 to −0.1466 | IGF1 |
| hsa-miR-320b | 1 | 1 | −0.1466 to −0.1466 | IGF1 |
| hsa-miR-18b-5p | 1 | 1 | −0.2185 to −0.2185 | IGF1 |
| hsa-miR-374a-5p | 1 | 1 | −0.511 to −0.511 | CCL2 |
| hsa-miR-26a-5p | 1 | 1 | −0.105 to −0.105 | IGF1 |
| hsa-miR-222-3p | 1 | 1 | −0.1612 to −0.1612 | IGF1 |
| hsa-miR-221-3p | 1 | 1 | −0.1612 to −0.1612 | IGF1 |
| hsa-miR-192-5p | 1 | 1 | −0.2211 to −0.2211 | IGF1 |
| hsa-miR-196a-5p | 1 | 1 | −0.0267 to −0.0267 | IGF1 |
| hsa-let-7f-5p | 1 | 1 | −0.1633 to −0.1633 | IGF1 |
| hsa-let-7a-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-miR-196b-5p | 1 | 1 | −0.0267 to −0.0267 | IGF1 |
| hsa-let-7b-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-let-7i-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-let-7e-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-let-7d-5p | 1 | 1 | −0.1612 to −0.1612 | IGF1 |
| hsa-let-7c-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-let-7g-5p | 1 | 1 | −0.1592 to −0.1592 | IGF1 |
| hsa-miR-576-5p | 1 | 1 | −0.1892 to −0.1892 | IGF1 |
aStrength scores are the Z scores derived from the TargetScan algorithm. A more negative number indicates a stronger score and an increased likelihood that the gene is a bona fide target for the miRNA evaluated.